Poliomyelitis amidst the COVID-19 pandemic in Africa: Efforts, challenges and recommendations.
Clin Epidemiol Glob Health
; 16: 101073, 2022.
Article
in English
| MEDLINE | ID: covidwho-1866946
ABSTRACT
Poliomyelitis is the leading infectious cause of acute flaccid paralysis among children under five years of age, caused by the Wild Poliovirus, with no medical cure other than prevention through vaccination. The advent of mass vaccination campaigns against polio disease worldwide has greatly decreased the number of global cases and limited the rate of transmission. However, the emergence of Vaccine-derived Poliovirus due to genetic reversions in the live attenuated oral polio vaccine has posed a significant impediment to global polio eradication efforts. Therefore, There is a need to modify the vaccination regimen by utilizing more doses of inactivated poliovirus vaccine or adopting the bivalent oral polio vaccine in order to eliminate the transmission of Vaccine-derived Poliovirus. In addition, collective efforts from governments, health policymakers, vaccination groups and health-related bodies are required to improve vaccine coverage and suppress the circulation of Vaccine-derived Poliovirus.
Africa; COVID-19; COVID-19, Coronavirus Disease 2019; GPEI, Global Polio Eradication Initiative; IPV, Inactivated Poliovirus Vaccine; OPV, Oral Polio Vaccine; Polio; Poliomyelitis; Poliovirus; SIAs, Supplementary Immunization Activities; VDPV, Vaccine-derived Poliovirus; Vaccine; WHO, World Health Organization; WPV, Wild Poliovirus; cVDPV, Circulating Vaccine-derived Poliovirus
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Randomized controlled trials
Topics:
Vaccines
Language:
English
Journal:
Clin Epidemiol Glob Health
Year:
2022
Document Type:
Article
Affiliation country:
J.cegh.2022.101073
Similar
MEDLINE
...
LILACS
LIS